ACRS
Price
$1.44
Change
+$0.06 (+4.35%)
Updated
May 2 closing price
Capitalization
155.92M
10 days until earnings call
BNR
Price
$2.79
Change
-$0.08 (-2.79%)
Updated
May 2 closing price
Capitalization
74.76M
Ad is loading...

ACRS vs BNR

Header iconACRS vs BNR Comparison
Open Charts ACRS vs BNRBanner chart's image
Aclaris Therapeutics
Price$1.44
Change+$0.06 (+4.35%)
Volume$668.87K
Capitalization155.92M
Burning Rock Biotech
Price$2.79
Change-$0.08 (-2.79%)
Volume$32.9K
Capitalization74.76M
ACRS vs BNR Comparison Chart
Loading...
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACRS vs. BNR commentary
May 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRS is a StrongBuy and BNR is a Hold.

Ad is loading...
COMPARISON
Comparison
May 04, 2025
Stock price -- (ACRS: $1.44 vs. BNR: $2.79)
Brand notoriety: ACRS and BNR are both not notable
ACRS represents the Biotechnology, while BNR is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ACRS: 68% vs. BNR: 222%
Market capitalization -- ACRS: $155.92M vs. BNR: $74.76M
ACRS [@Biotechnology] is valued at $155.92M. BNR’s [@Medical Specialties] market capitalization is $74.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.17B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B. The average market capitalization across the [@Medical Specialties] industry is $8.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRS’s FA Score shows that 1 FA rating(s) are green whileBNR’s FA Score has 1 green FA rating(s).

  • ACRS’s FA Score: 1 green, 4 red.
  • BNR’s FA Score: 1 green, 4 red.
According to our system of comparison, both ACRS and BNR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRS’s TA Score shows that 4 TA indicator(s) are bullish.

  • ACRS’s TA Score: 4 bullish, 5 bearish.

Price Growth

ACRS (@Biotechnology) experienced а +7.46% price change this week, while BNR (@Medical Specialties) price change was -1.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.26%. For the same industry, the average monthly price growth was -1.11%, and the average quarterly price growth was -1.23%.

Reported Earning Dates

ACRS is expected to report earnings on Aug 06, 2025.

BNR is expected to report earnings on Mar 25, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (+1.26% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACRS($156M) has a higher market cap than BNR($74.8M). ACRS YTD gains are higher at: -41.935 vs. BNR (-58.667). ACRS has higher annual earnings (EBITDA): -51.72M vs. BNR (-767.72M). BNR has more cash in the bank: 733M vs. ACRS (114M). BNR has higher revenues than ACRS: BNR (586M) vs ACRS (18.7M).
ACRSBNRACRS / BNR
Capitalization156M74.8M209%
EBITDA-51.72M-767.72M7%
Gain YTD-41.935-58.66771%
P/E RatioN/AN/A-
Revenue18.7M586M3%
Total Cash114M733M16%
Total DebtN/A30.5M-
FUNDAMENTALS RATINGS
ACRS: Fundamental Ratings
ACRS
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACRS
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLFMX8.06N/A
N/A
Harding Loevner Frontier Emerg Mkts Inst
FEYTX25.79N/A
N/A
Fidelity Advisor Asset Manager 85% M
MCSPX10.66N/A
N/A
BlackRock Advantage SMID Cap Inv C
NEFJX17.74N/A
N/A
Natixis Vaughan Nelson Small Cap A
LYRZX12.88N/A
N/A
Lyrical International Value Equity C

ACRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRS has been loosely correlated with PLLWF. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRS jumps, then PLLWF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRS
1D Price
Change %
ACRS100%
+4.35%
PLLWF - ACRS
64%
Loosely correlated
N/A
STRRP - ACRS
52%
Loosely correlated
+3.16%
MYNZ - ACRS
40%
Loosely correlated
-4.53%
UFPT - ACRS
39%
Loosely correlated
-4.77%
ANIK - ACRS
34%
Loosely correlated
+2.70%
More

BNR and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNR has been loosely correlated with SINT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BNR jumps, then SINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNR
1D Price
Change %
BNR100%
-2.79%
SINT - BNR
39%
Loosely correlated
+2.97%
ZOMDF - BNR
28%
Poorly correlated
-4.00%
ZIMV - BNR
28%
Poorly correlated
+3.54%
RVTY - BNR
25%
Poorly correlated
+1.17%
ACRS - BNR
24%
Poorly correlated
+4.35%
More